120 related articles for article (PubMed ID: 8272412)
1. Development of new lipophilic derivatives of tetragastrin: physicochemical characteristics and intestinal absorption of acyl-tetragastrin derivatives in rats.
Tenma T; Yodoya E; Tashima S; Fujita T; Murakami M; Yamamoto A; Muranishi S
Pharm Res; 1993 Oct; 10(10):1488-92. PubMed ID: 8272412
[TBL] [Abstract][Full Text] [Related]
2. Enhanced permeability of tetragastrin across the rat intestinal membrane and its reduced degradation by acylation with various fatty acids.
Yodoya E; Uemura K; Tenma T; Fujita T; Murakami M; Yamamoto A; Muranishi S
J Pharmacol Exp Ther; 1994 Dec; 271(3):1509-13. PubMed ID: 7996464
[TBL] [Abstract][Full Text] [Related]
3. [Improvement of intestinal absorption of peptide and protein drugs by chemical modification with fatty acids].
Yamamoto A
Nihon Rinsho; 1998 Mar; 56(3):601-7. PubMed ID: 9549343
[TBL] [Abstract][Full Text] [Related]
4. Permeability characteristics of tetragastrins across intestinal membranes using the Caco-2 monolayer system: comparison between acylation and application of protease inhibitors.
Fujita T; Kawahara I; Quan Y; Hattori K; Takenaka K; Muranishi S; Yamamoto A
Pharm Res; 1998 Sep; 15(9):1387-92. PubMed ID: 9755890
[TBL] [Abstract][Full Text] [Related]
5. Improvement of transdermal delivery of tetragastrin by lipophilic modification with fatty acids.
Setoh K; Murakami M; Araki N; Fujita T; Yamamoto A; Muranishi S
J Pharm Pharmacol; 1995 Oct; 47(10):808-11. PubMed ID: 8583347
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of prolonged administration of tetragastrin on experimentally induced intestinal metaplasia in Wistar rats.
Tatsuta M; Yamamura H; Baba M; Yamamoto R; Iishi H; Taniguchi H
Cancer; 1988 May; 61(10):2051-6. PubMed ID: 3359403
[TBL] [Abstract][Full Text] [Related]
7. Effect of cimetidine on inhibition by tetragastrin of carcinogenesis induced by N-methyl-N'-nitro-N-nitrosoguanidine in Wistar rats.
Tatsuta M; Iishi H; Yamamura H; Baba M; Yamamoto R; Taniguchi H
Cancer Res; 1988 Mar; 48(6):1591-5. PubMed ID: 3345530
[TBL] [Abstract][Full Text] [Related]
8. 'In vivo' amplification of biological activity of tetragastrin by amino acid hydroxamates.
Bali JP; Mattras H; Previero A; Coletti-Previero MA
Biosci Rep; 1984 Dec; 4(12):1009-15. PubMed ID: 6529604
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-8 enhances tetragastrin-stimulated acid secretion in vivo.
Yakabi K; Mimura H; Iwabuchi H; Ro S; Nakamura T
Dig Dis Sci; 1998 Oct; 43(10):2317-21. PubMed ID: 9790471
[TBL] [Abstract][Full Text] [Related]
10. Enhanced gastric acid secretion induced by gastrin can be suppressed by glucose injected into the portal vein in rats.
Sakaguchi T; Sandoh N; Aono T
Biochem Pharmacol; 1994 Jul; 48(1):205-6. PubMed ID: 8043025
[TBL] [Abstract][Full Text] [Related]
11. Absorption characteristics of chemically modified-insulin derivatives with various fatty acids in the small and large intestine.
Asada H; Douen T; Waki M; Adachi S; Fujita T; Yamamoto A; Muranishi S
J Pharm Sci; 1995 Jun; 84(6):682-7. PubMed ID: 7562404
[TBL] [Abstract][Full Text] [Related]
12. Neutrophil-derived hydroxyl radicals mediate interleukin-8-induced increases in tetragastrin-stimulated acid secretion in rats.
Yakabi K; Mimura H; Iwabuchi H; Ro S; Kamiichi H; Miura S; Nakamura T
Dig Dis Sci; 2003 Jun; 48(6):1081-7. PubMed ID: 12822866
[TBL] [Abstract][Full Text] [Related]
13. Enhancement by propranolol of the inhibitory effect of tetragastrin on gastric carcinogenesis induced by N-methyl-N'-nitro-N-nitrosoguanidine in Wistar rats.
Tatsuta M; Iishi H; Yamamura H; Taniguchi H
Cancer Res; 1987 Jan; 47(1):111-4. PubMed ID: 3791197
[TBL] [Abstract][Full Text] [Related]
14. Influence of L-365,260, a CCK-B/gastrin receptor antagonist, on tetragastrin-stimulated mucin metabolism in rat gastric mucosa.
Komuro Y; Ichikawa T; Ishihara K; Saigenji K; Hotta K
Pharmacology; 1999 Jul; 59(1):11-20. PubMed ID: 10352422
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of gastric acid secretion in the rhesus monkey.
Trout HH; Zinner M; Harmon JW
Dig Dis Sci; 1985 Jan; 30(1):82-7. PubMed ID: 3965277
[TBL] [Abstract][Full Text] [Related]
16. Enhancement by tetragastrin of experimental induction of gastric epithelium in the duodenum.
Tatsuta M; Iishi H; Yamamura H; Yamamoto R; Taniguchi H
Gut; 1989 Mar; 30(3):311-5. PubMed ID: 2707631
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of tetragastrin and histamine on carcinogenesis in the small intestines of W rats by N-methyl-N'-nitro-N-nitrosoguanidine.
Tatsuta M; Iishi H; Ichii M; Noguchi S; Yamamura H; Taniguchi H
J Natl Cancer Inst; 1986 Feb; 76(2):277-81. PubMed ID: 3456065
[TBL] [Abstract][Full Text] [Related]
18. Phenylethylamide derivatives of the C-terminal tetrapeptide of gastrin. Potent inhibitors of gastrin-stimulated acid secretion.
Martinez J; Rodriguez M; Bali JP; Laur J
Int J Pept Protein Res; 1986 Nov; 28(5):529-35. PubMed ID: 3818170
[TBL] [Abstract][Full Text] [Related]
19. [Delivery system design for improvement of intestinal absorption of peptide drugs].
Muranishi S
Yakugaku Zasshi; 1997 Jul; 117(7):394-414. PubMed ID: 9261212
[TBL] [Abstract][Full Text] [Related]
20. Enhanced transdermal delivery of phenylalanyl-glycine by chemical modification with various fatty acids.
Yamamoto A; Setoh K; Murakami M; Shironoshita M; Kobayashi T; Fujimoto K; Okada N; Fujita T; Muranishi S
Int J Pharm; 2003 Jan; 250(1):119-28. PubMed ID: 12480278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
